Enemeez® is a 5ml mini-enema of docusate sodium in a polyethylene glycol base and is dispensed using a soft latex-free tube. The tube has a twist off tip that leaves a smooth surface at the point of insertion. Enemeez® is effective for bowel care needs associated with spinal cord injury and disease, multiple sclerosis, traumatic brain injury, spina bifida, long-term care, stroke and constipation. Adults and children 12 years of age and older (with adult supervision), one to three units daily. Children under 12 years of age, consult a physician prior to use.
By implementing Enemeez usage across your facilities, both patients and facility will benefit by the following:
Fast, predictable results typically in 2-15 minutes1, non-irritating formula. No afterburn.
Can reduce nursing intervention required for in-patient bowel care; can result in labor cost savings to the facility.2
Can assist in the improvement of patient care and FIM scores associated with bowel care.
Can assist in reducing time spent with patient for dressing/redressing due to episodes of incontinence or fecal discharge.2
Can virtually eliminate episodes of incontinence3. Can assist in reducing complications of wound contamination associated with perianal pressure ulcers.
No mucosal discharge3; helps to maintain healthy skin integrity.
Easy rectal usage for patients with reflex issues or nausea.
Can assist in reducing time missed in therapy/rehabilitation due to episodes of incontinence, prolonged bowel care, or fatigue.2
Can assist with facility savings on pads, laundry, gowns, sheets, etc. due to incontinence or fecal discharge.
Enemeez® Plus is the same formula as Enemeez® with the addition of 20mg of benzocaine. This formula was developed for patients who experience pain or autonomic dysreflexia during their bowel movements. Enemeez® Plus should not be used when open sores are present.
1. Federal Register / Vol. 50, No. 10 / Tuesday, January 15, 1985 / Proposed Rules; pgs 2124-2158. 2. Rehabilitation Nursing (Dunn KL & Galka ML (1994) Comparison of the Effectiveness of Therevac SB and Bisacodyl Suppositories in SCI Patients Bowel Programs, Rehabil Nurs. 19 (6):334-8. 3. Alliance Labs In-house research. Customer Survey Nov. 6, 2009.